Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription.
about
Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Screening of an FDA-approved c ...... inhibits viral transcription.
@en
type
label
Screening of an FDA-approved c ...... inhibits viral transcription.
@en
prefLabel
Screening of an FDA-approved c ...... inhibits viral transcription.
@en
P2093
P2860
P1433
P1476
Screening of an FDA-approved c ...... t inhibits viral transcription
@en
P2093
Huachao Huang
Netty G Santoso
Sydney Simpson
Tsuyoshi Hayashi
P2860
P356
10.1016/J.ANTIVIRAL.2017.08.013
P50
P577
2017-08-24T00:00:00Z